SeaSpine gets FDA clearance for NanoMetalent surface tech

Spinal Tech

SeaSpine received FDA clearance to market its NanoMetalene surface technology for interbody devices, according to a Dec. 15 news release.

NanoMetalene technology incorporates a submicron layer of commercially pure titanium bonded to a PEEK implant with a high-energy, low temperature process, the release said. It's designed to provide a molecularly bonded layer of bone-friendly titanium on the implant.

The clearance allows SeaSpine to describe NanoMetalene as "providing a microscopic roughened surface with nano-scale features" and updates indications for use across the 12 implant systems, which it was previously applied. SeaSpine expects to use NanoMetalene with more implant systems over the next year.

Read more details here.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers